Dr. Luis Pineiro, MD

Dr. Pineiro practices at Baylor University Medical Center in Dallas, Texas, part of Baylor Scott & White Health.

Dr. Pineiro's NPI, 1144263633, was assigned on June 13, 2006. Dr. Pineiro graduated from University of Puerto Rico, Medical Sciences Campus in 1983. Dr. Pineiro holds Texas license J0632.

Dr. Pineiro's primary practice is Baylor University Medical Center, at 3500 Gaston Ave, Dallas, TX 75246 in Dallas County. The practice phone is (214) 820-8082.

Dr. Pineiro's primary practice is Baylor University Medical Center in Dallas, Texas, part of Baylor Scott & White Health. Dr. Pineiro is also affiliated with Baylor Scott & White Institute for Rehabilitation - Dallas. The medical group on file is Texas Oncology. Dmand AI also links Dr. Pineiro to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pineiro practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Pineiro's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Pineiro is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Pineiro's licenses on file in 2 states: Texas and Florida.

Dmand AI lists anemia, chronic anemia, chronic leukemia, colorectal cancer, lymphoma and multiple myeloma among the conditions Dr. Pineiro treats.

CMS data shows 4,487 Medicare services from Dr. Pineiro across 24 procedure codes in 2024, for 164 Medicare patients. Medicare paid $159,928 for them.

CMS counts 164 Medicare patients who saw Dr. Pineiro in 2024. The largest group is 65 to 74, with 96 patients. 72% of them have high blood pressure, and 56% have high cholesterol. Their average risk score is 2.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pineiro's median patient age at 63, with 41% women.

In 2024, Dr. Pineiro wrote 1,437 Medicare Part D claims for 116 patients. 84% of them were for generic drugs. CMS names the drug for 1,084 of them, across 41 drugs with 11 or more claims each, at $3,077,450 in total drug cost. In 2023, CMS named 883 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Pineiro for performance year 2024, reported through an alternative payment model (APM). Dr. Pineiro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pineiro as offering telehealth.

Dmand AI links 16 papers to Dr. Pineiro, published from 2009 to 2023. The most frequent topics are Bone Marrow Transplantation, Etoposide and Cyclophosphamide. Dr. Pineiro has published most often in Bone Marrow Transplant. Dr. Pineiro's most frequent co-authors are Robert Howard Collins, MD, John Greer, MD and Mark R. Litzow, MD.

Dmand AI links Dr. Pineiro to 1 clinical trial. Conditions studied include Myelodysplastic Syndromes and Bone Marrow Diseases.

CMS Open Payments shows 555 general payments to Dr. Pineiro from 46 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Alexion Pharmaceuticals, Inc. paid the most, $94,699.

Dmand AI lists 1 award for Dr. Pineiro, most recently CMS Stage 1 2012 in 2012.

Dr. Pineiro graduated from University of Puerto Rico, Medical Sciences Campus in 1983.

Dr. Pineiro is in network with 24 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.